  I present here longitudinal evaluation of T and B cell immunity to SARS-CoV2
and variants of concern (VOC) from a single subject (me) over an entire year
post vaccination. After enrolling in the Moderna phase III clinical trial, I
collected my own biological samples pre- and post-immunization in the event of
being a recipient of the experimental vaccine. The evidence strongly supports
the conclusion that I did not receive the placebo. The analysis is admittedly
limited to an n of 1, but the results fit well with data taken from published
works and represent one of the more comprehensive longitudinal evaluations of
vaccine-elicited immunity within a single individual yet to be undertaken.
Though the data amount to a well-documented anecdote, given its granularity, it
is not without its insights and may be of further use in directing future
longitudinal studies that have actual statistical significance.
